BioSpace News Archive

Partnership Accelerates Development Path for Mirvetuximab in Greater China and Expands Huadong Medicine’s Oncology Portfolio with Innovative ADC Combines ImmunoGen’s Lead Clinical Program with Huadong’s Regional Oncology Expertise ImmunoGen to Receive $40 Million Upfront Payment and is Eligible to Receive Up to $265 Million in Potential Development, Regulatory, and Commercial Milestone Payments

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter ended September 30, 2020 will be released before market open on Monday, Nov 2, 2020. Quotient will host a conference call to discuss its second quarter financial results at 8:00 a.m. Eastern Time the same day. Participants may access the call by dialing 1-877-407-0784 in the U.S. or 1-201-689-85

Global health service company Cigna Corporation (NYSE:CI) announced today that Eric Palmer , Executive Vice President and Chief Financial Officer, will present at the Credit Suisse 29 th Annual Healthcare Conference on November 9, 2020 through a virtual webcast.

(“AbbVie”) announced today the commencement of its offers to exchange (the “Registered Exchange Offers”) any and all of its outstanding (i) $30,000,000,000 aggregate principal amount of senior unsecured notes previously issued on November 21, 2019 (the " 2019 USD Notes”), (ii) $13,251,781,000 aggregate principal amount

Cynosure announced the appointment of Sujat Sukthankar , former VP of Platform Engineering at Becton Dickinson and Vice President of R&D at Boston Scientific, as the Company’s Executive Vice President of Research & Product D

Enzolytics, Inc. shared the update provided by ENZC’s Merger target BioClonetics Immunotherapeutics, Inc., to its Investors, Shareholders and Supporters.

Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it will begin its donor study as a precursor for its FDA EUA, EU CE Mark and Russian Federation testing of its Genviro! Saliva Swift Kit for the detection of Covid-19.

Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today announced that it has partnered with American Preclinical Services in a first of its kind study to improve Glioblastoma outcomes.

Chemomab Ltd., a clinical-stage biotech company focusing on discovery and development of innovative therapeutics for fibrosis-related diseases, today announces that clinical data from its phase Ib study of CM-101 in non-alcoholic fatty liver disease (NAFLD) patients will be presented as a late-breaking poster presentation at The Liver Meeting Digital Experience™ 2020

Known as the “Mother Theresa of Healthcare”, Abubakar Earns Award for Tireless Service to Community Health and Advancing Pharmacy Education